KLK3 and benign prostatic hyperplasia: Based on this scenario, in previous papers, we showed increased plasmatic levels of PSA-expressing exosomes in PCa patients compared to BPH and CTR subjects, supporting the clinical relevance of exosomes as tumor biomarkers (35, 36).